Tekla Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Tekla Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.22K	Hold	6,000	–	–	﹤0.01%	166
2023 Q1	$1.98K	Hold	6,000	–	–	﹤0.01%	177
2022 Q4	$4.32K	Hold	6,000	–	–	﹤0.01%	172
2022 Q3	$7K	Hold	6,000	–	–	﹤0.01%	167
2022 Q2	$7K	Hold	6,000	–	–	﹤0.01%	177
2022 Q1	$13K	Hold	6,000	–	–	﹤0.01%	174
2021 Q4	$9K	Hold	6,000	–	–	﹤0.01%	171
2021 Q3	$18K	Hold	6,000	–	–	﹤0.01%	172
2021 Q2	$20K	Hold	6,000	–	–	﹤0.01%	188
2021 Q1	$23K	Hold	6,000	–	–	﹤0.01%	195
2020 Q4	$21K	Hold	6,000	–	–	﹤0.01%	199
2020 Q3	$39K	Hold	6,000	–	–	﹤0.01%	202
2020 Q2	$45K	Hold	6,000	–	–	﹤0.01%	222
2020 Q1	$28K	Hold	6,000	–	–	﹤0.01%	214
2019 Q4	$77K	Hold	6,000	–	–	﹤0.01%	212
2019 Q3	$63K	Hold	6,000	–	–	﹤0.01%	190
2019 Q2	$102K	Hold	6,000	–	–	﹤0.01%	195
2019 Q1	$202K	Hold	6,000	–	–	0.01%	191
2018 Q4	$175K	Hold	6,000	–	–	0.01%	199
2018 Q3	$370K	Hold	6,000	–	–	0.01%	202
2018 Q2	$443K	Hold	6,000	–	–	0.02%	170
2018 Q1	$394K	Hold	6,000	–	–	0.02%	180
2017 Q4	$505K	Hold	6,000	–	–	0.02%	152
2017 Q3	$693K	Hold	6,000	–	–	0.02%	139
2017 Q2	$701K	Hold	6,000	–	–	0.03%	131
2017 Q1	$740K	Hold	6,000	–	–	0.03%	128
2016 Q4	$817K	Hold	6,000	–	–	0.03%	133
2016 Q3	$1.19M	Hold	6,000	–	–	0.05%	132
2016 Q2	$778K	Hold	6,000	–	–	0.03%	150
2016 Q1	$561K	Hold	6,000	–	–	0.02%	134
2015 Q4	$1.22M	Hold	6,000	–	–	0.04%	126
2015 Q3	$872K	Hold	6,000	–	–	0.03%	152
2015 Q2	$1.28M	Hold	6,000	–	–	0.05%	103
2015 Q1	$1.39M	Hold	6,000	–	–	0.06%	110
2014 Q4	$1.38M	Buy	+6,000	New	+$1.29M	0.06%	86

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Tekla Capital Management's BLCM Position: Q2 2023 in Review

Tekla Capital Management held its Bellicum Pharmaceuticals, Inc. (BLCM) position steady in Q2 2023 at 6,000 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #166.

Tekla Capital Management first reported a position in BLCM in Q4 2014 and has held it in 35 quarters since. The position peaked at $1.39M in Q1 2015. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Tekla Capital Management held 6,000 shares of Bellicum Pharmaceuticals, Inc. worth $2.22K as of Q2 2023.
Tekla Capital Management left its Bellicum Pharmaceuticals, Inc. share count unchanged in Q2 2023.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of Tekla Capital Management's portfolio in Q2 2023, its #166 holding.
Tekla Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and has held it in 35 quarters since.
Tekla Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.39M in Q1 2015.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.